Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Goodwill & Intangibles (2016 - 2021)

Vycor Medical has reported Goodwill & Intangibles over the past 12 years, most recently at $865639.0 for Q4 2021.

  • Quarterly Goodwill & Intangibles rose 7527.45% to $865639.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $865639.0 through Dec 2021, up 7527.45% year-over-year, with the annual reading at $865639.0 for FY2021, 7527.45% up from the prior year.
  • Goodwill & Intangibles was $865639.0 for Q4 2021 at Vycor Medical, up from $2366.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $865639.0 in Q4 2021 and troughed at $2366.0 in Q3 2021.
  • The 5-year median for Goodwill & Intangibles is $251157.0 (2017), against an average of $193557.0.
  • Year-over-year, Goodwill & Intangibles plummeted 85.94% in 2018 and then soared 7527.45% in 2021.
  • A 5-year view of Goodwill & Intangibles shows it stood at $251157.0 in 2017, then plummeted by 85.94% to $35303.0 in 2018, then tumbled by 33.93% to $23326.0 in 2019, then crashed by 51.35% to $11349.0 in 2020, then soared by 7527.45% to $865639.0 in 2021.
  • Per Business Quant, the three most recent readings for VYCO's Goodwill & Intangibles are $865639.0 (Q4 2021), $2366.0 (Q3 2021), and $5361.0 (Q2 2021).